Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Satraplatin for Patients With Metastatic Breast Cancer (MBC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
PhII ICb With/Without Erbitux in MBC Pts
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment
- Status
- TERMINATED
- Phase
- PHASE4
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2